an experimental drug does not prove itself
Sanofi announced on September 2, 2024 that its experimental multiple sclerosis drug tolebrutinib failed to meet the primary endpoint of two late-stage clinical trials. September 2, 2024 • By Handicap.fr with AFP Disappointment. On September 2, 2024, the French pharmaceutical group Sanofi indicated in a press release that the treatment studied did not demonstrate a … Read more